The global flat panel detector (FPD)-based X-ray for cone beam computed tomography (CBCT) market size was estimated at USD 2.13 billion in 2017. It is expected to expand at a CAGR of 8.07% over the forecast period. Significant advantages of FPD technology over charge coupled devices (CCDs) & image intensifying detectors (IIDs) are poised to fuel the adoption of FPD-based X-rays for CBCT.
CBCT works with two dimensional X-ray detectors. Many cone beam CT systems are designed using a combination of CCD camera and X-ray image intensifier. However, owing to various advantages of FPDs, these have replaced CCD in CBCT systems.
High volume coverage, high (150 μm) spatial resolution, and ability to perform fluoroscopy/angiography in conjunction with tomography are advantages of using flat panel detectors for CBCT. These advantages are increasing their clinical applications. FPD made from complementary metal-oxide-semiconductor (CMOS) or amorphous silicon drive the digital radiology revolution by making X-rays safer for patients with the use of low radiation dose.
The use of FPD-based X-rays for 3D imaging is limited to assessment of osseous structures due to poor soft tissue contrast. However, key players are involved in the investigation of several techniques and devices to widen the scope. Growing focus on research and development is anticipated to positively influence the adoption rate of the technology in medical imaging beyond dental and ENT applications.
Considerable improvements in reimbursement scenario for traditional as well as advanced CT scans are resulting in an increase in the number of scans done through advanced digital systems and acceptance in the patient base. This, in turn, is bolstering the adoption of 3D CT scans among physicians and diagnostic labs. Abilities of FPDs to produce larger, as well as smaller FOV, are triggering their preference to conventional tools such as IIDs or CCDs, FPDs are replacing these detectors in the imaging market.
The use of flat panel detectors for clinical cone beam CT has witnessed noteworthy expansion from diagnostic imaging to image-guided surgery. For instance, manufacturers are engaged in designing a unit of C-arm for 3D intraoperative imaging by integrating FPD, X-ray tube, computer workstation, mobile C-arm platform, displays, and other accessories.
In terms of revenue, orthopedic was the most prominent application segment in the market in 2017 owing to the early developments of x-ray technology in orthopedic imaging. Furthermore, manufacturers are involved in the development of novel platforms to enhance the applicability of these systems.
For instance, in March 2018, Siemens Healthineers introduced a new version of Cios Select, which combines FPD technology and customary image intensifier. This device is designed to enable intraoperative imaging for orthopedics, peripheral vascular surgery, pain management, urology, and trauma. A combination of FPDs with different technologies such as CCDs and IIDs to enhance applicability is projected to enhance product portfolio.
Based on product, the market has been segmented into sitting, standing, and lying down. Although systems for all three positions are commercially available, a majority of the systems function with combined (sitting + standing) patient position.
Although sitting X-rays are more preferred by most practitioners, the high cost of these devices limits their adoption in most developing and underdeveloped countries. Lower cost compared to sitting x-ray devices is contributing to the growth of the standing X-ray segment. In addition, flexibility in use for adult and pediatric patients and less area occupancy are helping the segment dominate the FPD-based X-ray for the CBCT market throughout the forecast period.
Systems offering lying down (supine/prone) positioning are very limited in the market. Limited commercial availability, high cost, and large size of these systems are poised to inhibit the growth of the segment. Nevertheless, their popularity is gradually rising, owing to which the segment is likely to post the highest CAGR during the forecast period.
Hospitals are the major end users of FPD-based CBCT devices with over 41.0% share in the overall market revenue in 2017. Higher demand for such units and imaging systems in hospitals consequently affects the installation rate. Furthermore, highly sophisticated systems, which generate higher revenue through sales, are being increasingly installed by hospitals for the purpose of surgical assistance.
Novel systems in the market usually are coming in portable sizes. Besides this, declining cost of flat panel detectors is expected to increase the installation of in-house FPD-based X-ray CBCT devices at diagnostics centers. Owing to this, the segment is estimated to exhibit promising growth during the forecast period.
North America led the global market in 2017, due to the well-established supply network of major players. Rapid uptake of novel tools is resulting in higher sales of medical devices and associated technologies in this region. Following North America, Europe accounted for a significant revenue share in the market in the same year.
However, Middle East & Africa (MEA) is anticipated to experience the fastest CAGR during the forecast period. The growth of the region can be attributed to economic development and rising investments in healthcare facilities & infrastructure. However, the absence of specific guidelines pertaining to the use of advanced technologies such as CBCT is keeping the market in the region from attaining size comparable to developed regions. Nevertheless, rising penetration of players in the region is projected to augur well for the regional market in the near future.
The global arena is consolidated with a well-established distribution network of a few multinational players. Key strategies adopted by these players include new product development, expansion of service facilities, and collaborations. Mature players are involved in broadening their service portfolio while emerging players are engaged in strengthening their distribution network.
Key competitors for the market include PointNix Co., Ltd; J. Morita Corp.; Genoray Co., Ltd.; Xoran Technologies, LLC; CurveBeam; ASAHI ROENTGEN IND.CO., LTD.; Owandy Radiology; Carestream Health; Dentsply Sirona; i-CAT; Teledyne DALSA Inc.; Cefla s.c. (NewTom S.C); Varex Imaging Corporation; PLANMECA OY; Ray Co. Ltd; Danaher (KaVo Kerr, Gendex, PaloDEx Group); and VATECH.
Report Attribute |
Details |
Market size value in 2020 |
USD 2.7 billion |
Revenue forecast in 2025 |
USD 3.96 billion |
Growth Rate |
CAGR of 8.07% from 2018 to 2025 |
Base year for estimation |
2017 |
Historical data |
2014 – 2016 |
Forecast period |
2018 – 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Application, product, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Spain; Japan; China; India; South Korea; Brazil; Mexico; South Africa |
Key companies profiled |
PointNix Co., Ltd; J. Morita Corp.; Genoray Co., Ltd.; Xoran Technologies, LLC; CurveBeam; ASAHI ROENTGEN IND.CO., LTD.; Owandy Radiology; Carestream Health; Dentsply Sirona; i-CAT; Teledyne DALSA Inc.; Cefla s.c. (NewTom S.C); Varex Imaging Corporation; PLANMECA OY; Ray Co. Ltd; Danaher (KaVo Kerr, Gendex, PaloDEx Group); VATECH |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global FPD-based X-ray for CBCT market report on the basis of application, product, end use, and region:
Application Outlook (Revenue, USD Million, 2014 - 2025)
Dental
Implantology
Orthodontics
Oral Surgery
Endodontics
Periodontology
Other Dental Applications
ENT
Orthopedics
Other Applications
Product Outlook (Revenue, USD Million, 2014 - 2025)
Sitting
Standing
Lying Down
End-User Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Clinics
Diagnostics Centers
Other End Users
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Spain
Asia Pacific
Japan
China
India
South Korea
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Amongst the majorly used Covid-19 screening options, imaging is preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging modalities including nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. These are used in theories such as comparison of the vulnerability of pediatric and geriatric patients, and treatment response for several drug combinations. The rising requirement for advanced lung imaging solutions is expected to boost the development studies for lung phantoms. A detailed study on lung deterioration in Covid-19 patients is expected to provide advanced measures for early detection of the disease. The report will account for Covid19 as a key market contributor.